Critically, patients with a high frequency of MD+ B cells displayed significantly lower serum concentrations of autoantibodies, IL‐6 and CRP, suggesting the role of MD in suppressing pathogenic B‐cell response in COVID‐19 patients. The gene discussed is IL6; the disease is COVID-19.